The key industry bodies from across Europe have signed a letter to UK Brexit minister David Davis and EU chief Brexit negotiator Michel Barnier saying the UK must stay in the European Medicines Agency system
Don’t mention the B word: the first major reform of R&D funding since 1965 aims to make the UK the “go-to place” for science. But in setting out the vision, no reference was made to Brexit and its implications
While other countries have assessed the overall impact of Brexit, Sweden is alone in analysing the specific effects on R&D. There could be severe consequences for the size and shape of Framework Programmes that will reverberate through Swedish research
Try as they might, no one can see a bright side to Brexit, either for the UK or the EU27. The only course is damage limitation, agreed speakers at a debate ‘Brexit the scientific impact’
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.